Cardioversion in patients with newly diagnosed non-valvular atrial fibrillation: observational study using prospectively collected registry data
OBJECTIVE: To investigate the clinical outcomes of patients who underwent cardioversion compared with those who did not have cardioverson in a large dataset of patients with recent onset non-valvular atrial fibrillation. DESIGN: Observational study using prospectively collected registry data (Global...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
29 September 2021
|
| In: |
The BMJ
Year: 2021, Jahrgang: 375, Pages: 1-10 |
| ISSN: | 1756-1833 |
| DOI: | 10.1136/bmj-2021-066450 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1136/bmj-2021-066450 Verlag, lizenzpflichtig, Volltext: https://www.bmj.com/content/375/bmj-2021-066450 
|
| Verfasserangaben: | Marita Knudsen Pope, Trygve S. Hall, Valentina Schirripa, Petra Radic, Saverio Virdone, Karen S. Pieper, Jean-Yves Le Heuzey, Petr Jansky, David A. Fitzmaurice, Riccardo Cappato, Dan Atar, A. John Camm, Ajay K. Kakkar, on behalf of the GARFIELD-AF investigators, Werner Hacke [und zahlreiche Andere] |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1777254868 | ||
| 003 | DE-627 | ||
| 005 | 20230426124428.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 211111s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1136/bmj-2021-066450 |2 doi | |
| 035 | |a (DE-627)1777254868 | ||
| 035 | |a (DE-599)KXP1777254868 | ||
| 035 | |a (OCoLC)1341423864 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Pope, Marita Knudsen |e VerfasserIn |0 (DE-588)124556045X |0 (DE-627)1777256844 |4 aut | |
| 245 | 1 | 0 | |a Cardioversion in patients with newly diagnosed non-valvular atrial fibrillation |b observational study using prospectively collected registry data |c Marita Knudsen Pope, Trygve S. Hall, Valentina Schirripa, Petra Radic, Saverio Virdone, Karen S. Pieper, Jean-Yves Le Heuzey, Petr Jansky, David A. Fitzmaurice, Riccardo Cappato, Dan Atar, A. John Camm, Ajay K. Kakkar, on behalf of the GARFIELD-AF investigators, Werner Hacke [und zahlreiche Andere] |
| 264 | 1 | |c 29 September 2021 | |
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 11.11.2021 | ||
| 520 | |a OBJECTIVE: To investigate the clinical outcomes of patients who underwent cardioversion compared with those who did not have cardioverson in a large dataset of patients with recent onset non-valvular atrial fibrillation. DESIGN: Observational study using prospectively collected registry data (Global Anticoagulant Registry in the FIELD-AF-GARFIELD-AF). SETTING: 1317 participating sites in 35 countries. PARTICIPANTS: 52 057 patients aged 18 years and older with newly diagnosed atrial fibrillation (up to six weeks' duration) and at least one investigator determined stroke risk factor. MAIN OUTCOME MEASURES: Comparisons were made between patients who received cardioversion and those who had no cardioversion at baseline, and between patients who received direct current cardioversion and those who had pharmacological cardioversion. Overlap propensity weighting with Cox proportional hazards models was used to evaluate the effect of cardioversion on clinical endpoints (all cause mortality, non-haemorrhagic stroke or systemic embolism, and major bleeding), adjusting for baseline risk and patient selection. RESULTS: 44 201 patients were included in the analysis comparing cardioversion and no cardioversion, and of these, 6595 (14.9%) underwent cardioversion at baseline. The propensity score weighted hazard ratio for all cause mortality in the cardioversion group was 0.74 (95% confidence interval 0.63 to 0.86) from baseline to one year follow-up and 0.77 (0.64 to 0.93) from one year to two year follow-up. Of the 6595 patients who had cardioversion at baseline, 299 had a follow-up cardioversion more than 48 days after enrolment. 7175 patients were assessed in the analysis comparing type of cardioversion: 2427 (33.8%) received pharmacological cardioversion and 4748 (66.2%) had direct current cardioversion. During one year follow-up, event rates (per 100 patient years) for all cause mortality in patients who received direct current and pharmacological cardioversion were 1.36 (1.13 to 1.64) and 1.70 (1.35 to 2.14), respectively. CONCLUSION: In this large dataset of patients with recent onset non-valvular atrial fibrillation, a small proportion were treated with cardioversion. Direct current cardioversion was performed twice as often as pharmacological cardioversion, and there appeared to be no major difference in outcome events for these two cardioversion modalities. For the overall cardioversion group, after adjustments for confounders, a significantly lower risk of mortality was found in patients who received early cardioversion compared with those who did not receive early cardioversion. STUDY REGISTRATION: ClinicalTrials.gov NCT01090362. | ||
| 650 | 4 | |a Aged | |
| 650 | 4 | |a Atrial Fibrillation | |
| 650 | 4 | |a Cause of Death | |
| 650 | 4 | |a Electric Countershock | |
| 650 | 4 | |a Female | |
| 650 | 4 | |a Humans | |
| 650 | 4 | |a Male | |
| 650 | 4 | |a Middle Aged | |
| 650 | 4 | |a Propensity Score | |
| 650 | 4 | |a Proportional Hazards Models | |
| 650 | 4 | |a Prospective Studies | |
| 650 | 4 | |a Registries | |
| 650 | 4 | |a Therapeutics | |
| 700 | 1 | |a Hall, Trygve S. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schirripa, Valentina |e VerfasserIn |4 aut | |
| 700 | 1 | |a Radic, Petra |e VerfasserIn |4 aut | |
| 700 | 1 | |a Virdone, Saverio |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pieper, Karen S. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Le Heuzey, Jean-Yves |e VerfasserIn |4 aut | |
| 700 | 1 | |a Jansky, Petr |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fitzmaurice, David A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Cappato, Riccardo |e VerfasserIn |4 aut | |
| 700 | 1 | |a Atar, Dan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Camm, A. John |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kakkar, Ajay K. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hacke, Werner |d 1948- |e VerfasserIn |0 (DE-588)12021699X |0 (DE-627)080530346 |0 (DE-576)164358854 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The BMJ |d London : BMJ Publ. Group, 1988 |g 375(2021), Artikel-ID e066450, Seite 1-10 |h Online-Ressource |w (DE-627)271349190 |w (DE-600)1479799-9 |w (DE-576)078590574 |x 1756-1833 |7 nnas |a Cardioversion in patients with newly diagnosed non-valvular atrial fibrillation observational study using prospectively collected registry data |
| 773 | 1 | 8 | |g volume:375 |g year:2021 |g elocationid:e066450 |g pages:1-10 |g extent:10 |a Cardioversion in patients with newly diagnosed non-valvular atrial fibrillation observational study using prospectively collected registry data |
| 856 | 4 | 0 | |u https://doi.org/10.1136/bmj-2021-066450 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.bmj.com/content/375/bmj-2021-066450 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20211111 | ||
| 993 | |a Article | ||
| 994 | |a 2021 | ||
| 998 | |g 12021699X |a Hacke, Werner |m 12021699X:Hacke, Werner |d 50000 |e 50000PH12021699X |k 0/50000/ |p 20 | ||
| 999 | |a KXP-PPN1777254868 |e 4001539454 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 11.11.2021"],"title":[{"title_sort":"Cardioversion in patients with newly diagnosed non-valvular atrial fibrillation","title":"Cardioversion in patients with newly diagnosed non-valvular atrial fibrillation","subtitle":"observational study using prospectively collected registry data"}],"person":[{"display":"Pope, Marita Knudsen","family":"Pope","roleDisplay":"VerfasserIn","given":"Marita Knudsen","role":"aut"},{"roleDisplay":"VerfasserIn","family":"Hall","display":"Hall, Trygve S.","given":"Trygve S.","role":"aut"},{"given":"Valentina","role":"aut","roleDisplay":"VerfasserIn","family":"Schirripa","display":"Schirripa, Valentina"},{"roleDisplay":"VerfasserIn","display":"Radic, Petra","family":"Radic","given":"Petra","role":"aut"},{"given":"Saverio","role":"aut","roleDisplay":"VerfasserIn","family":"Virdone","display":"Virdone, Saverio"},{"given":"Karen S.","role":"aut","roleDisplay":"VerfasserIn","family":"Pieper","display":"Pieper, Karen S."},{"family":"Le Heuzey","display":"Le Heuzey, Jean-Yves","roleDisplay":"VerfasserIn","given":"Jean-Yves","role":"aut"},{"family":"Jansky","display":"Jansky, Petr","roleDisplay":"VerfasserIn","role":"aut","given":"Petr"},{"role":"aut","given":"David A.","family":"Fitzmaurice","display":"Fitzmaurice, David A.","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","family":"Cappato","display":"Cappato, Riccardo","given":"Riccardo","role":"aut"},{"roleDisplay":"VerfasserIn","family":"Atar","display":"Atar, Dan","given":"Dan","role":"aut"},{"given":"A. John","role":"aut","family":"Camm","display":"Camm, A. John","roleDisplay":"VerfasserIn"},{"family":"Kakkar","display":"Kakkar, Ajay K.","roleDisplay":"VerfasserIn","given":"Ajay K.","role":"aut"},{"given":"Werner","role":"aut","roleDisplay":"VerfasserIn","family":"Hacke","display":"Hacke, Werner"}],"recId":"1777254868","language":["eng"],"id":{"doi":["10.1136/bmj-2021-066450"],"eki":["1777254868"]},"physDesc":[{"extent":"10 S."}],"name":{"displayForm":["Marita Knudsen Pope, Trygve S. Hall, Valentina Schirripa, Petra Radic, Saverio Virdone, Karen S. Pieper, Jean-Yves Le Heuzey, Petr Jansky, David A. Fitzmaurice, Riccardo Cappato, Dan Atar, A. John Camm, Ajay K. Kakkar, on behalf of the GARFIELD-AF investigators, Werner Hacke [und zahlreiche Andere]"]},"relHost":[{"id":{"eki":["271349190"],"zdb":["1479799-9"],"issn":["1756-1833"]},"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"recId":"271349190","titleAlt":[{"title":"BMJ. British medical journal (Clinical research ed.)"}],"note":["Gesehen am 02.10.20"],"title":[{"title_sort":"BMJ","title":"The BMJ"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"publisherPlace":"London","dateIssuedKey":"1988","dateIssuedDisp":"1988-","publisher":"BMJ Publ. Group"}],"pubHistory":["297.1988 -"],"disp":"Cardioversion in patients with newly diagnosed non-valvular atrial fibrillation observational study using prospectively collected registry dataThe BMJ","part":{"text":"375(2021), Artikel-ID e066450, Seite 1-10","pages":"1-10","extent":"10","year":"2021","volume":"375"}}],"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"29 September 2021"}]} | ||
| SRT | |a POPEMARITACARDIOVERS2920 | ||